Berkay Kilic

Dr. Berkay Kilic

istanbul university oncology institute, Istanbul, İstanbul, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2013 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
OAOrhan Agcaoglu
Orhan Agcaoglu
NANihat Aksakal
Nihat Aksakal
BOBeyza Ozcinar
Beyza Ozcinar
ISInanc S. Sarici
Inanc S. Sarici
GEGulcin Ercan
Gulcin Ercan
YEYesim Erbil
Yesim Erbil
Background. The purpose of this study was to assess the factors that affect the false-negative outcomes of fine-needle aspiration biopsies (FNABs) in thyroid nodules.Methods. Thyroid nodules that underwent FNAB and surgery between August 2005 and January 2012 were analyzed. FNABs were taken from the suspicious nodules regardless of nodule size.Results. Nodules were analyzed in 2 different groups: Group 1 was the false-negatives (n=81) and Group 2 was the remaining true-positives, true-negatives, and false-positives (n=649). A cytopathologist attended in 559 (77%) of FNAB procedures. There was a positive correlation between the nodule size and false-negative rates, and the absence of an interpreting cytopathologist for the examination of the FNAB procedure was the most significant parameter with a 76-fold increased risk of false-negative results.Conclusion. The contribution of cytopathologists extends the time of the procedure, and this could be a difficult practice in centres with high patient turnovers. We currently request the contribution of a cytopathologist for selected patients whom should be followed up without surgery.

1 August 2017 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
PDF file
DŞDuygu Has Şimşek
Duygu Has Şimşek
YŞYasemin Şanli
Yasemin Şanli
CKCemil B. Külle
Cemil B. Külle
HKHasan Karanlik
Hasan Karanlik
BKBerkay Kilic
Berkay Kilic
VÖVahit Özmen
Vahit Özmen
The aim of this study was to determine the correlation between the primary tumor (PT) maximum standardized uptake value (SUVmax) and breast cancer prognostic factors, overall survival, and relapse-free survival on the basis of histopathological and molecular characteristics. In this retrospective study, 436 female patients with breast cancer were evaluated following a pretreatment 18F-FDG PET/CT scan. The PT SUVmax and histopathological/molecular characteristics were determined from primary tumor tissues and analyzed using the Mann–Whitney U and Kruskal–Wallis tests. The median SUVmax of 436 PT was 10.1 (1.7–72). The PT SUVmax values were higher in ER− versus ER+ (P=0.001), PR− versus PR+ (P=0.001), Her2+ versus Her2− (P=0.01), Ki-67% of at least 20 versus Ki-67% of less than 20 (P<0.001), histological grade 3 versus grade 1–2 (P<0.001), nuclear pleomorphism score 3 versus score 1–2 (P<0.001), and mitotic score 3 versus score 1–2 patients (P<0.001). The lowest SUVmax levels were observed in the LumA group and the highest SUVmax levels were observed in the Her2 group (P<0.001). LumA patients with PR values greater than 20% had lower PT SUVmax values than the patients with PR values of 20% or less (P=0.023). The PT SUVmax was higher in patients with recurrence (P=0.03) and died related to disease (P<0.001) independent of time. The PT SUVmax showed a significant correlation with most of the prognostic factors and histopathological subtypes as a noninvasive tool. It is also usable in the prediction of tumor-related deaths or relapse independent of time. Our results could guide future studies to provide new histopathologic subtype definitions on the basis of new PR criteria.

25 April 2015 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
HKHasan Karanlik
Hasan Karanlik
HOHatice Odabas
Hatice Odabas
IYIlknur Yildirim
Ilknur Yildirim
IOIlker Ozgur
Ilker Ozgur
BKBerkay Kilic
Berkay Kilic
AAAdnan Aydiner
Adnan Aydiner

25 October 2016 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HKHasan Karanlik
Hasan Karanlik
IOIlker Ozgur
Ilker Ozgur
BKBerkay Kilic
Berkay Kilic
AFAlisan Fathalizadeh
Alisan Fathalizadeh
YSYasemin Sanli
Yasemin Sanli
BGBahadir M. Gulluoglu
Bahadir M. Gulluoglu

1 June 2013 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Closed access
UBUmut Barbaros
Umut Barbaros
IÖİbRahim A. Özemir
İbRahim A. Özemir
NANihat Aksakal
Nihat Aksakal
MTMustafa Tükenmez
Mustafa Tükenmez
BKBerkay Kilic
Berkay Kilic
SMSelçuk Mercan
Selçuk Mercan
Visceral artery aneurysms are rare and important vascular entities due to the quarter of all cases presented as surgical emergency. Nevertheless, splenic artery aneurysm (SAA) is the most common visceral and third most common intra-abdominal artery aneurysm after aorta and iliac artery. SAA accompany splenic vein aneurysm because arteriovenous fistula communication between them is a very rare entity. Location and size of the SAA determine the likelihood of rupture. Women of child-bearing age who have SAAs are at particularly high risk of death as a result of aneurysm rupture and should be treated with elective repair. Herein, we report a case of a splenic artery and vein aneurysm with arteriovenous fistula in a 25-year-old young female patient who presented with left upper quadrant pain. Diagnosis was established by computerized tomography angiogram. The patient underwent laparoscopic resection of splenic artery and vein, as well as with splenectomy. Laparoscopic therapy for SAA should be considered for the patient with a low periprocedural morbidity at experienced surgical clinics.

14 June 2023 in Breast Care
Verified
Journal Article
Open access
BKBerkay Kilic
Berkay Kilic
SBSuleyman Bademler
Suleyman Bademler
BIBurak Ilhan
Burak Ilhan
IYIlknur Yildirim
Ilknur Yildirim
SKSeden Kucucuk
Seden Kucucuk
HKHasan Karanlik
Hasan Karanlik
Introduction: We aimed to report the long-term surgical outcomes of extreme oncoplasty techniques in selected patients with unifocal (UF)/cT3 or multifocal-multicentric tumors (MFMC). Material and Methods: Patients who were initially recommended to have mastectomy underwent extreme oncoplastic breast-conserving surgery (eOBCS) including therapeutic reduction mammoplasty, racquet, and round-block mammoplasty, Grisotti flap, or combined technique were included. Preoperative tumor parameters, clinical outcomes, rate of local recurrence, survival, and patients’ satisfaction were assessed. Results: Eighty-six patients with a median age of 51 years were followed for a median follow-up of 75 (8–154) months; 31 (36%) had cT3 and 55 (64%) had MFMC tumors. The majority of patients (83.6%) had invasive cancer. The median UF tumor size was 58 mm (range 51–100) on imaging and 51 mm (range 50–60) on final pathology. The median tumor span for MFMC was 65 mm (range 53–95) on imaging, whereas the median of the largest tumor size was 30 mm (range 22–60) on final pathology. Seventy-one patients (82.5%) were ER-positive, 17 (19.7%) were HER2 positive, and 8 (9.3%) were triple-negative breast cancer. Four patients (4.7%) required further intervention for having positive margins (3 re-excisions, 1 completion mastectomy). Three local recurrences (3.4%) and 10 (11.6%) distant metastasis occurred. The cosmetic outcome was excellent in 37 (43%) patients. No major complications were observed. Conclusions: eOBCS can be a good option for patients who initially require mastectomy. Appropriate patient selection, a multidisciplinary approach, and patient consent are essential steps of the procedure.